BioCryst Pharmaceuticals BCRX Compensation and benefits
Compensation and benefits at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's compensation and benefits?
- BioCryst Pharmaceuticals (BCRX) reported compensation and benefits of $16.03M in Q1 2026.
- How has BioCryst Pharmaceuticals's compensation and benefits changed year-over-year?
- BioCryst Pharmaceuticals's compensation and benefits decreased by 25.0% year-over-year, from $21.37M to $16.03M.
- What is the long-term trend for BioCryst Pharmaceuticals's compensation and benefits?
- Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's compensation and benefits has grown at a 25.2% compound annual growth rate (CAGR), from $34.64M to $85.07M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.